MR evaluation of portal hypertensive collateral shunting vessels for predicting outcome after transjugular intrahepatic portosystemic shunt

Magnetic Resonance in Medical Sciences

Volumn 10, Issue 1, 2011, Pages 21-27

  Yoshikawa, Takeshi ^a,b   Mitchell, Donald G ^a  

^a Division of Magnetic Resonance Imaging   (United States)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Abdomen; Cirrhosis; Magnetic resonance imaging; Portal hypertension; Trans jugular portosystemic shunt

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; COLLATERAL CIRCULATION; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HUMAN; INFERIOR CAVA VEIN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COLLATERAL CIRCULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; HYPERTENSION, PORTAL; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENA CAVA, INFERIOR;

EID: 79960965705     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.10.21     Document Type: Review

References (23)

1. Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41:386-400.
2. Roässle M, Grandt D. TIPS: an update. Best Pract Res Clin Gastroenterol 2004; 18:99-123.
3. Boyer TD. Transjugular intrahepatic portosystem-ic shunt: current status. Gastroenterology 2003; 124:1700-1710.
4. McCashland TM. Current use of transjugular in-trahepatic portosystemic shunts. Curr Gastroen-terol Rep 2003; 5:31-38.
5. McCormick PA, Dick R, Panagou EB, et al. Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81:1324-1327.
6. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
7. Ferral H, Patel NH. Selection criteria for patients undergoing transjugular intrahepatic portosystem-ic shunt procedures: current status. J Vasc Interv Radiol 2005; 16: 449-455.
8. Pan JJ, Chen C, Caridi JG, et al. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical center. J Vasc Interv Radiol 2008; 19:1576-1581.
9. Cakmak O, Elmas N, Tamsel S, et al. Role of contrast-enhanced 3D magnetic resonance por-tography in evaluating portal venous system compared with color Doppler ultrasonography. Ab-dom Imaging 2008; 33:65-71.
10. Lee MW, Lee JM, Lee JY, et al. Preoperative evaluation of the hepatic vascular anatomy in living liver donors: comparison of CT angiography and MR angiography. J Magn Reson Imaging 2006; 24:1081-1087.
11. Yoshikawa T, Ohno Y, Motohara T, et al. Gadolinium-enhanced phase-contrast magnetic resonance portography. Magn Reson Med Sci 2005; 4:165-174.
12. Amano Y, Takahama K, Nozaki A, Amano M, Kumazaki T. Magnetic resonance portography using contrast-enhanced fat-saturated three-dimensional steady-state free precession imaging. J Magn Reson Imaging 2004; 19:238-244.
13. Carr JC, Nemcek AA Jr, Abecassis M, et al. Preoperative evaluation of the entire hepatic vas culature in living liver donors with use of contrast-enhanced MR angiography and true fast imaging with steady-state precession. J Vasc Interv Radiol 2003; 14:441-449.
14. Kim M, Mitchell DG, Ito K. Portosystemic collaterals of the upper abdomen: review of anatomy and demonstration on MR imaging. Abdom Imaging 2000; 25:462-470.
15. Haskal ZJ, Martin L, Cardella JF, et al. Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003; 14:S265-S270.
16. Lafortune M, Marleau D, Breton G, Viallet A, Lavoie P, Huet PM. Portal venous system measurements in portal hypertension. Radiology 1984; 151:27-30.
17. Bryce TJ, Yeh BM, Qayyum A, et al. CT signs of hepatofugal portal venous ‰ow in patients with cirrhosis. AJR Am J Roentgenol 2003; 181:1629-1633.
18. Brancatelli G, Federle MP, Pealer K, Geller DA. Portal venous thrombosis or sclerosis in liver transplantation candidates: preoperative CT findings and correlation with surgical procedure. Radiology 2001; 220:321-328.
19. Aseni P, Beati C, Brambilla G, Bertini M, Belli L. Does large spontaneous portal systemic shunt in cirrhosis protect from the risk of gastroesophageal bleeding? J Clin Gastroenterol 1986; 8:235-238.
20. Ohnishi K, Sato S, Saito M, et al. Clinical and portal hemodynamic features in cirrhotic patients having a large spontaneous splenorenal and/or gas-trorenal shunt. Am J Gastroenterol 1986; 81:450-455.
21. Ito K, Matsutani S, Maruyama H, et al. Study of hemodynamic changes in portal systemic shunts and their relation to variceal relapse after endo-scopic variceal ligation combined with ethanol sclerotherapy. J Gastroenterol 2006; 41:119-126.
22. Jung HS, Kalva SP, Greenfield AJ, et al. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetra‰uoro-ethylene stent-grafts. J Vasc Interv Radiol 2009; 20:180-185.
23. Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetra‰uoroethylene in patients treated by transjugular intrahepatic por-tosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27:742-747.